Impact of HLA class I alterations in cancer patients undergoing T cell specific immunotherapy

被引：0
|
作者：
Méndez, R [1 ]
Ruiz-Cabello, F [1 ]
Jiménez, P [1 ]
Cabrera, T [1 ]
López-Nevot, MA [1 ]
Knuth, A [1 ]
Jager, E [1 ]
Traversari, C [1 ]
Schadendorff, D [1 ]
Boon, T [1 ]
Garrido, F [1 ]
机构：
[1] Hosp Univ, Serv Anal Clin, Granada, Spain
来源：
TISSUE ANTIGENS | 2002年 / 59卷
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页码：32 / 32
页数：1
相关论文
共 50 条
  • [21] HLA class I loss in colorectal cancer: implications for immune escape and immunotherapy
    Anderson, Per
    Aptsiauri, Natalia
    Ruiz-Cabello, Francisco
    Garrido, Federico
    CELLULAR & MOLECULAR IMMUNOLOGY, 2021, 18 (03) : 556 - 565
  • [22] Evolutionary divergence of HLA class I genotype impacts efficacy of cancer immunotherapy
    Diego Chowell
    Chirag Krishna
    Federica Pierini
    Vladimir Makarov
    Naiyer A. Rizvi
    Fengshen Kuo
    Luc G. T. Morris
    Nadeem Riaz
    Tobias L. Lenz
    Timothy A. Chan
    Nature Medicine, 2019, 25 : 1715 - 1720
  • [23] Improving T Cell Assays Using HLA Class I or Class II Mono-specific APCs/Targets
    Savage, Philip
    JOURNAL OF IMMUNOTHERAPY, 2008, 31 (09) : 938 - 938
  • [24] Clinical impact of HLA class I expression in rectal cancer
    Frank M. Speetjens
    Elza C. de Bruin
    Hans Morreau
    Eliane C. M. Zeestraten
    Hein Putter
    J. Han van Krieken
    Maaike M. van Buren
    Monique van Velzen
    N. Geeske Dekker-Ensink
    Cornelis J. H. van de Velde
    Peter J. K. Kuppen
    Cancer Immunology, Immunotherapy, 2008, 57 : 601 - 609
  • [25] Clinical impact of HLA class I expression in rectal cancer
    Speetjens, Frank M.
    de Bruin, Elza C.
    Morreau, Hans
    Zeestraten, Eliane C. M.
    Putter, Hein
    van Krieken, J. Han
    van Buren, Maaike M.
    van Velzen, Monique
    Dekker-Ensink, N. Geeske
    de Velde, Cornelis J. H. van
    Kuppen, Peter J. K.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2008, 57 (05) : 601 - 609
  • [26] The impact of amino-acid substitutions at specific positions of the HLA class I molecules on alloreactive T-cell precursor frequencies
    Heemskerk, MBA
    Dankers, MKA
    Roelen, DL
    van Rood, JJ
    Claas, FHJ
    Doxiadis, IIN
    Oudshoorn, M
    GENES AND IMMUNITY, 2004, 5 : S9 - S9
  • [27] High-resolution analysis of HLA class I alterations in colorectal cancer
    Jan Willem F Dierssen
    Noel FCC de Miranda
    Arend Mulder
    Marjo van Puijenbroek
    Willem Verduyn
    Frans HJ Claas
    Cornelis JH van de Velde
    Gert Jan Fleuren
    Cees J Cornelisse
    Willem E Corver
    Hans Morreau
    BMC Cancer, 6
  • [28] High-resolution analysis of HLA class I alterations in colorectal cancer
    Dierssen, Jan Willem F.
    De Miranda, Noel F. C. C.
    Mulder, Arend
    van Puijenbroek, Marjo
    Verduyn, Willem
    Claas, Frans H. J.
    de Velde, Cornelis J. H. van
    Fleuren, Gert Jan
    Cornelisse, Cees J.
    Corver, Willem E.
    Morreau, Hans
    BMC CANCER, 2006, 6 (1)
  • [29] Reversible epigenetic alterations regulate class I HLA loss in prostate cancer
    Tamara S. Rodems
    Erika Heninger
    Charlotte N. Stahlfeld
    Cole S. Gilsdorf
    Kristin N. Carlson
    Madison R. Kircher
    Anupama Singh
    Timothy E. G. Krueger
    David J. Beebe
    David F. Jarrard
    Douglas G. McNeel
    Michael C. Haffner
    Joshua M. Lang
    Communications Biology, 5
  • [30] Reversible epigenetic alterations regulate class I HLA loss in prostate cancer
    Rodems, Tamara S.
    Henninger, Erika
    Stahlfeld, Charlotte N.
    Gilsdorf, Cole S.
    Carlson, Kristin N.
    Kircher, Madison R.
    Singh, Anupama
    Krueger, Timothy E. G.
    Beebe, David J.
    Jarrard, David F.
    McNeel, Douglas G.
    Haffner, Michael C.
    Lang, Joshua M.
    COMMUNICATIONS BIOLOGY, 2022, 5 (01)
12345